Although the results from both cohorts slightly varied, the analysis revealed that predominant variables predictive of OS and PFS in MDS patients are high blast counts, high levels of the H19 transcript, and presence of somatic mutations in the TP53 gene. This evidence concerns the gene H19 and myelodysplastic syndrome.